ArticleSensors (Basel, Switzerland)2022
Performance Analysis of State-of-the-Art CNN Architectures for LUNA16.
Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- A Novel Hybrid Technique for Detecting and Classifying Hyperspectral Images of Tomato Fungal Diseases Based on Deep Feature Extraction and Manhattan Distance.Sensors (Basel, Switzerland) · 2025Article
- A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer.Cancers · 2025Review
- A novel benign and malignant classification model for lung nodules based on multi-scale interleaved fusion integrated network.Scientific reports · 2024Article
- The artistic image processing for visual healing in smart city.Scientific reports · 2024Article
- Augmenting Radiological Diagnostics with AI for Tuberculosis and COVID-19 Disease Detection: Deep Learning Detection of Chest Radiographs.Diagnostics (Basel, Switzerland) · 2024Article
- Optimization of convolutional neural network and visual geometry group-16 using genetic algorithms for pneumonia detection.Frontiers in medicine · 2024Article
- Artificial intelligence-based forensic sex determination of East Asian cadavers from skull morphology.Scientific reports · 2023Article
- A comprehensive analysis of recent advancements in cancer detection using machine learning and deep learning models for improved diagnostics.Journal of cancer research and clinical oncology · 2023Review
- A Novel FDLSR-Based Technique for View-Independent Vehicle Make and Model Recognition.Sensors (Basel, Switzerland) · 2023Article
- A review and comparative study of cancer detection using machine learning: SBERT and SimCSE application.BMC bioinformatics · 2023Review
- Sensor Data Fusion Based on Deep Learning for Computer Vision Applications and Medical Applications.Sensors (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The convolutional neural network (CNN) has become a powerful tool in machine learning (ML) that is used to solve complex problems such as image recognition, natural language processing, and video analysis. Notably, the idea of exploring convolutional neural network architecture has gained substantial attention as well as popularity. This study focuses on the intrinsic various CNN architectures: LeNet, AlexNet, VGG16, ResNet-50, and Inception-V1, which have been scrutinized and compared with each other for the detection of lung cancer using publicly available LUNA16 datasets. Furthermore, multiple performance optimizers: root mean square propagation (RMSProp), adaptive moment estimation (Adam), and stochastic gradient descent (SGD), were applied for this comparative study. The performances of the three CNN architectures were measured for accuracy, specificity, sensitivity, positive predictive value, false omission rate, negative predictive value, and F1 score. The experimental results showed that the CNN AlexNet architecture with the SGD optimizer achieved the highest validation accuracy for CT lung cancer with an accuracy of 97.42%, misclassification rate of 2.58%, 97.58% sensitivity, 97.25% specificity, 97.58% positive predictive value, 97.25% negative predictive value, false omission rate of 2.75%, and F1 score of 97.58%. AlexNet with the SGD optimizer was the best and outperformed compared to the other state-of-the-art CNN architectures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.